{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:48:10Z","timestamp":1789681690646,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C60192\/A28516"],"award-info":[{"award-number":["C60192\/A28516"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2020,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Although prostate cancer is a leading cause of cancer death, its aetiology is not well understood. We aimed to identify novel biochemical factors for prostate cancer incidence and mortality in UK Biobank.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A range of cardiovascular, bone, joint, diabetes, renal and liver-related biomarkers were measured in baseline blood samples collected from up to 211,754 men at recruitment and in a subsample 5 years later. Participants were followed-up via linkage to health administrative datasets to identify prostate cancer cases. Hazard ratios (HRs) and 95% confidence intervals were calculated using multivariable-adjusted Cox regression corrected for regression dilution bias. Multiple testing was accounted for by using a false discovery rate controlling procedure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After an average follow-up of 6.9 years, 5763 prostate cancer cases and 331 prostate cancer deaths were ascertained. Prostate cancer incidence was positively associated with circulating vitamin D, urea and phosphate concentrations and inversely associated with glucose, total protein and aspartate aminotransferase. Phosphate and cystatin-C were the only biomarkers positively and inversely, respectively, associated with risk in analyses excluding the first 4 years of follow-up. There was little evidence of associations with prostate cancer death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We found novel associations of several biomarkers with prostate cancer incidence. Future research will examine associations by tumour characteristics.<\/jats:p><\/jats:sec>","DOI":"10.1038\/s41416-020-01081-3","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T01:02:46Z","timestamp":1600822966000},"page":"1808-1817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank"],"prefix":"10.1038","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-356X","authenticated-orcid":false,"given":"Aurora","family":"Perez-Cornago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina K.","family":"Fensom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor L.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi E.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7992-7719","authenticated-orcid":false,"given":"Richard M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Key","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth C.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359\u2013E386 (2015).","journal-title":"Int. J. Cancer"},{"key":"1081_CR2","unstructured":"WCRF\/AICR. World Cancer Research Fund International\/American Institute for Cancer Research Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Prostate Cancer. http:\/\/www.wcrf.org\/sites\/default\/files\/Prostate-Cancer-SLR-2014.pdf (2014)."},{"key":"1081_CR3","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/S1470-2045(14)70211-6","volume":"15","author":"J Cuzick","year":"2014","unstructured":"Cuzick, J., Thorat, M. A., Andriole, G., Brawley, O. W., Brown, P. H., Culig, Z. et al. Prevention and early detection of prostate cancer. Lancet Oncol. 15, e484\u2013e492 (2014).","journal-title":"Lancet Oncol."},{"key":"1081_CR4","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/0008-5472.CAN-15-1551","volume":"76","author":"RC Travis","year":"2016","unstructured":"Travis, R. C., Appleby, P. N., Martin, R. M., Holly, J. M., Albanes, D., Black, A. et al. A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk. Cancer Res. 76, 2288\u20132300 (2016).","journal-title":"Cancer Res."},{"key":"1081_CR5","doi-asserted-by":"publisher","unstructured":"Watts, E. L., Goldacre, R., Key, T. J., Allen, N. E., Travis, R. C. & Perez-Cornago, A. Hormone-related diseases and prostate cancer: an English national record linkage study. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.32808 (2019).","DOI":"10.1002\/ijc.32808"},{"key":"1081_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0876-7","volume":"15","author":"A Perez-Cornago","year":"2017","unstructured":"Perez-Cornago, A., Appleby, P. N., Pischon, T., Tsilidis, K. K., Tjonneland, A., Olsen, A. et al. Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study. BMC Med. 15, 115 (2017).","journal-title":"BMC Med."},{"key":"1081_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.eururo.2018.07.024","volume":"74","author":"EL Watts","year":"2018","unstructured":"Watts, E. L., Appleby, P. N., Perez-Cornago, A., Bueno-de-Mesquita, H. B., Chan, J. M., Chen, C. et al. Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies. Eur. Urol. 74, 585\u2013594 (2018).","journal-title":"Eur. Urol."},{"key":"1081_CR8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/bjc.2017.312","volume":"117","author":"A Perez-Cornago","year":"2017","unstructured":"Perez-Cornago, A., Key, T. J., Allen, N. E., Fensom, G. K., Bradbury, K. E., Martin, R. M. et al. Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study. Br. J. Cancer 117, 1562\u20131571 (2017).","journal-title":"Br. J. Cancer"},{"key":"1081_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2532-6","volume":"16","author":"G Wong","year":"2016","unstructured":"Wong, G., Staplin, N., Emberson, J., Baigent, C., Turner, R., Chalmers, J. et al. Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer 16, 488 (2016).","journal-title":"BMC Cancer"},{"key":"1081_CR10","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).","journal-title":"PLoS Med."},{"key":"1081_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T. et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am. J. Epidemiol. 186, 1026\u20131034 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"1081_CR12","unstructured":"UK Biobank. UK Biobank Anthropometry. http:\/\/biobank.ctsu.ox.ac.uk\/crystal\/docs\/Anthropometry.pdf (2014)."},{"key":"1081_CR13","unstructured":"UK Biobank. Repeat assessment data https:\/\/biobank.ctsu.ox.ac.uk\/~bbdatan\/Repeat_assessment_doc_v1.0.pdf (2013)."},{"key":"1081_CR14","unstructured":"Sheard, S. M. & Froggatt, J. UK Biobank Haematology Data Companion Document [Internet]. https:\/\/biobank.ctsu.ox.ac.uk\/crystal\/docs\/haematology.pdf (2017)."},{"key":"1081_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott, P., Peakman, T. C. & Biobank, U. K. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int. J. Epidemiol. 37, 234\u2013244 (2008).","journal-title":"Int. J. Epidemiol."},{"key":"1081_CR16","unstructured":"UK Biobank. Protocol for a Large-scale Prospective Epidemiological Resource [Internet]. http:\/\/www.ukbiobank.ac.uk\/wp-content\/uploads\/2011\/11\/UK-Biobank-Protocol.pdf (2007)."},{"key":"1081_CR17","unstructured":"WHO. International statistical classification of diseases and related health problems. 10th revision. http:\/\/apps.who.int\/classifications\/icd10\/browse\/2010\/en (2010)."},{"key":"1081_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","volume":"150","author":"R Clarke","year":"1999","unstructured":"Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M. et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am. J. Epidemiol. 150, 341\u2013353 (1999).","journal-title":"Am. J. Epidemiol."},{"key":"1081_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","volume":"335","author":"S MacMahon","year":"1990","unstructured":"MacMahon, S., Peto, R., Cutler, J., Collins, R., Sorlie, P., Neaton, J. et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335, 765\u2013774 (1990).","journal-title":"Lancet"},{"key":"1081_CR20","unstructured":"UK Biobank. Biomarker assay quality procedures: approaches used to minimise systematic and random errors (and the wider epidemiological implications). Secondary Biomarker assay quality procedures: approaches used to minimise systematic and random errors (and the wider epidemiological implications). http:\/\/biobank.ctsu.ox.ac.uk\/showcase\/docs\/biomarker_issues.pdf (2019)."},{"key":"1081_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate\u2014a -practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"},{"key":"1081_CR22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1158\/1055-9965.EPI-14-1329","volume":"24","author":"L YuPeng","year":"2015","unstructured":"YuPeng, L., YuXue, Z., PengFei, L., Cheng, C., YaShuang, Z., DaPeng, L. et al. Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies. Cancer Epidemiol. Biomark. Prev. 24, 1086\u20131093 (2015).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1081_CR23","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/cam4.695","volume":"5","author":"CJ Bull","year":"2016","unstructured":"Bull, C. J., Bonilla, C., Holly, J. M., Perks, C. M., Davies, N., Haycock, P. et al. Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Med. 5, 1125\u20131136 (2016).","journal-title":"Cancer Med."},{"key":"1081_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10552-011-9774-z","volume":"22","author":"M Van Hemelrijck","year":"2011","unstructured":"Van Hemelrijck, M., Walldius, G., Jungner, I., Hammar, N., Garmo, H., Binda, E. et al. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study. Cancer Causes Control 22, 1011\u20131019 (2011).","journal-title":"Cancer Causes Control"},{"key":"1081_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10654-014-9884-5","volume":"29","author":"M His","year":"2014","unstructured":"His, M., Zelek, L., Deschasaux, M., Pouchieu, C., Kesse-Guyot, E., Hercberg, S. et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur. J. Epidemiol. 29, 119\u2013132 (2014).","journal-title":"Eur. J. Epidemiol."},{"key":"1081_CR26","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1200\/JCO.2006.07.1381","volume":"24","author":"C Siemes","year":"2006","unstructured":"Siemes, C., Visser, L. E., Coebergh, J. W., Splinter, T. A., Witteman, J. C., Uitterlinden, A. G. et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J. Clin. Oncol. 24, 5216\u20135222 (2006).","journal-title":"J. Clin. Oncol."},{"key":"1081_CR27","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/ijc.24241","volume":"124","author":"JR Stark","year":"2009","unstructured":"Stark, J. R., Li, H., Kraft, P., Kurth, T., Giovannucci, E. L., Stampfer, M. J. et al. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int. J. Cancer 124, 2683\u20132689 (2009).","journal-title":"Int. J. Cancer"},{"key":"1081_CR28","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/ijc.31256","volume":"142","author":"R Arthur","year":"2018","unstructured":"Arthur, R., Williams, R., Garmo, H., Holmberg, L., Stattin, P., Malmstrom, H. et al. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study. Int. J. Cancer 142, 2254\u20132262 (2018).","journal-title":"Int. J. Cancer"},{"key":"1081_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1158\/0008-5472.CAN-18-2318","volume":"79","author":"RC Travis","year":"2019","unstructured":"Travis, R. C., Perez-Cornago, A., Appleby, P. N., Albanes, D., Joshu, C. E., Lutsey, P. L. et al. A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk. Cancer Res. 79, 274\u2013285 (2019).","journal-title":"Cancer Res."},{"key":"1081_CR30","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1158\/1055-9965.EPI-08-0365","volume":"17","author":"HG Skinner","year":"2008","unstructured":"Skinner, H. G. & Schwartz, G. G. Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol. Biomark. Prev. 17, 2302\u20132305 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1081_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10552-012-9948-3","volume":"23","author":"J Brandstedt","year":"2012","unstructured":"Brandstedt, J., Almquist, M., Manjer, J. & Malm, J. Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study. Cancer Causes Control 23, 1377\u20131385 (2012).","journal-title":"Cancer Causes Control"},{"key":"1081_CR32","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10552-018-1081-5","volume":"29","author":"J Yarmolinsky","year":"2018","unstructured":"Yarmolinsky, J., Berryman, K., Langdon, R., Bonilla, C., consortium, P., Davey Smith, G. et al. Mendelian randomization does not support serum calcium in prostate cancer risk. Cancer Causes Control 29, 1073\u20131080 (2018).","journal-title":"Cancer Causes Control"},{"key":"1081_CR33","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E. & Ioannidis, J. P. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350, g7607 (2015).","journal-title":"BMJ"},{"key":"1081_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/1940-6207.CAPR-18-0216","volume":"12","author":"MT Marrone","year":"2019","unstructured":"Marrone, M. T., Selvin, E., Barber, J. R., Platz, E. A. & Joshu, C. E. Hyperglycemia, classified with multiple biomarkers simultaneously in men without diabetes, and risk of fatal prostate cancer. Cancer Prev. Res. (Philos.) 12, 103\u2013112 (2019).","journal-title":"Cancer Prev. Res. (Philos.)"},{"key":"1081_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/ndt\/gfq397","volume":"26","author":"JJ Carrero","year":"2011","unstructured":"Carrero, J. J., Qureshi, A. R., Nakashima, A., Arver, S., Parini, P., Lindholm, B. et al. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol. Dial. Transpl. 26, 184\u2013190 (2011).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1081_CR36","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00467-012-2175-z","volume":"27","author":"M Goretti Penido","year":"2012","unstructured":"Goretti Penido, M. & Alon, U. S. Phosphate homeostasis and its role in bone health. Pediatr. Nephrol. 27, 2039\u20132048 (2012).","journal-title":"Pediatr. Nephrol."},{"key":"1081_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3945\/ajcn.114.088716","volume":"101","author":"KM Wilson","year":"2015","unstructured":"Wilson, K. M., Shui, I. M., Mucci, L. A. & Giovannucci, E. Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study. Am. J. Clin. Nutr. 101, 173\u2013183 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"1081_CR38","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3945\/ajcn.114.102715","volume":"102","author":"LW Moore","year":"2015","unstructured":"Moore, L. W., Nolte, J. V., Gaber, A. O. & Suki, W. N. Association of dietary phosphate and serum phosphorus concentration by levels of kidney function. Am. J. Clin. Nutr. 102, 444\u2013453 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"1081_CR39","doi-asserted-by":"publisher","first-page":"e0201308","DOI":"10.1371\/journal.pone.0201308","volume":"13","author":"YJ Choi","year":"2018","unstructured":"Choi, Y. J., Lee, D. H., Han, K. D., Yoon, H., Shin, C. M., Park, Y. S. et al. Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men. PLoS ONE 13, e0201308 (2018).","journal-title":"PLoS ONE"},{"key":"1081_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1530\/ERC-14-0036","volume":"21","author":"WM Choi","year":"2014","unstructured":"Choi, W. M., Lee, J. H., Yoon, J. H., Kwak, C., Lee, Y. J., Cho, Y. Y. et al. Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence. Endocr. Relat. Cancer 21, 343\u2013353 (2014).","journal-title":"Endocr. Relat. Cancer"},{"key":"1081_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1872-034X.2011.00915.x","volume":"42","author":"Y Arase","year":"2012","unstructured":"Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N. et al. Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients. Hepatol. Res. 42, 264\u2013272 (2012).","journal-title":"Hepatol. Res."},{"key":"1081_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ije\/dyx206","volume":"47","author":"MR Munafo","year":"2018","unstructured":"Munafo, M. R., Tilling, K., Taylor, A. E., Evans, D. M. & Smith, G. D. Collider scope: when selection bias can substantially influence observed associations. Int. J. Epidemiol. 47, 226\u2013235 (2018).","journal-title":"Int. J. Epidemiol."},{"key":"1081_CR43","doi-asserted-by":"publisher","first-page":"m131","DOI":"10.1136\/bmj.m131","volume":"368","author":"GD Batty","year":"2020","unstructured":"Batty, G. D., Gale, C. R., Kivimaki, M., Deary, I. J. & Bell, S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ 368, m131 (2020).","journal-title":"BMJ"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01081-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01081-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01081-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:25:32Z","timestamp":1723649132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01081-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,8]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-01081-3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"17 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee (reference number 06\/MRE08\/65). At recruitment, all participants gave informed consent to participate and for their health to be followed-up through linkage to their health-related records.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This work has been conducted using the UK Biobank Resource under Application Number 3282. Bona-fide researchers can apply to use the UK Biobank dataset by registering and applying at","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"These analyses were supported by a Cancer Research UK Population Research Fellowship (C60192\/A28516) to APC and a Cancer Research UK Programme Grant (C8221\/A29017). R.M.M. is supported in part by the National Institute for Health Research Bristol Biomedical Research Centre and by a Cancer Research UK (C18281\/A19169) programme grant (the Integrative Cancer Epidemiology Programme).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}